{
    "code": "01036857",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036857",
    "time": "2020-02-25 06:10:31",
    "許可證字號": "衛署藥製字第036857號",
    "註銷狀態": "已註銷",
    "註銷日期": "97\/10\/29",
    "註銷理由": "自請註銷",
    "有效日期": "97\/10\/22",
    "發證日期": "82\/10\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103685707",
    "中文品名": "敵血栓糖衣錠２５０公絲（梯可比定）",
    "英文品名": "DECLOT S.C. TABLETS 250MG (TICLOPIDINE) &quot;WEIDAR&quot;",
    "適應症": "適用於曾發生完成性栓塞型中風（ＣＯＭＰＬＥＴＥＤ　ＴＨＲＯＭＢＯＴＩＣＳＴＲＯＫＥ）及有中風前兆（ＳＴＲＯＫＥ　ＰＲＥＣＵＲＳＯＲＳ），且不適於使用ＡＳＰＩＲＩＮ之患者。",
    "劑型": "119糖衣錠",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1605609200  衛達化學製藥股份有限公司",
        "申請商地址": "台中巿工業區２３路２１號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600110",
            "成分名稱": "TICLOPIDINE HCL",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ]
}